| 영문 | hyperplasia | 한글 | 과다형성, 증식 |
|---|---|---|---|
| 설명 | 기능항진을 유발시키는 자극을 받았을 때 분열이 가능한 세포가 세포분열로 그 수가 증가되는 것을 증식이라 하며, 결과적으로 그 조직이나 장기도 커지게 된다. 비대는 단순히 세포의 증식이 없이 세포의 크기가 커지는 경우를 이르는 말이다. |
||
| 영문 | Benign Prostatic Hyperplasia(BPH) | 한글 | 전립샘비대 |
|---|---|---|---|
| 설명 | 50세 이상의 남성에 빈발하는 병으로 전립샘의 요도 주위 영역에 큰결절을 형성하여, 이것이 커지면 요도를 압박하여 부분적 혹은 완전한 요도폐색을 일으키는 병이다. 증상은 요도폐색에 따른 소변의 감소와 방광자극증상으로 빈뇨, 잔뇨감, 소변을 참을 수 없는 증상 등이다. 치료는 경요도 전립샘 적출술로 전립선의 비대한 부분을 절제해야 한다. |
||
| IPEH | intravascular papillary endothelial hyperplasia |
|---|---|
| MEN | Multiple Endocrine Neoplasia ; AD Trait 1. MEN Type I(= Wermer Syndro... |
| FH | facial hemihyperplasia; familial hypercholesterolemia; family history; fasting hyperbilirubinemia; f... |
| RES | Reticulo-Endothelial System |
| ARES | antireticulo-endothelial serum |
| IPEH | Intravascular Papillary Endothelial Hyperplasia |
|---|---|
| AH | Adenomatous hyperplasia |
| ALHE | Angiolymphoid hyperplasia with eosinophilia |
| AAH | Atypical adenomatous hyperplasia |
| ADH | Atypical ductal hyperplasia |
| intravascular papillary endothelial hyperplasia | A benign florid papillary endothelial proliferation within the veins of the skin or subcutis, less often in visceral blood vessels. Synonym: Masson's pseudoangiosarcoma. (05 Mar 2000) |
|---|---|
| vascular endothelial growth factor | A growth factor that is responsible for the growth of blood vessels. (12 Dec 1998) |
| platelet endothelial cell activated protease | <enzyme> Degrades casein and fibrinogen; secreted by endothelial cells and activated in the extracellular medium by platelets; not inhibited by serine protease inhibitors, metalloproteinase inhibitors, or cystein protease inhibitors; pH optimum 7.5 Registry number: EC 3.4.99.- Synonym: pecap (26 Jun 1999) |
| corneal endothelial polymorphism | A greater than normal variation in the shape of the cells. (05 Mar 2000) |
| high endothelial postcapillary venules | Venule's in the lymph nodes, tonsils, and Peyer's patches that have a high-walled endothelium through which blood lymphocytes migrate into the lymphatic parenchyma. (05 Mar 2000) |
| iridocorneal endothelial syndrome | <syndrome> Syndrome of glaucoma, iris atrophy, decreased corneal endothelium, anterior peripheral synechia, and multiple iris nodules. Synonym: Cogan-Reese syndrome, iris-nevus syndrome. (05 Mar 2000) |
| endothelial | Pertaining to or made up of endothelium. (16 Dec 1997) |
| endothelial cell | A thin, flattened cell, a layer of them lines the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium. (09 Oct 1997) |
| endothelial cyst | A serous cyst whose sac is lined with endothelium. (05 Mar 2000) |
| endothelial dystrophy of cornea | Spontaneous loss of corneal endothelium leading to oedema of the corneal stroma and epithelium. (05 Mar 2000) |
| endothelial growth factors | These growth factors are soluble mitogens secreted by a variety of organs. The factors are a mixture of two single chain polypeptides which have affinity to heparin. Their molecular weight are organ and species dependent. They have mitogenic and chemotactic effects and can stimulate endothelial cells to grow and synthesise DNA. The factors are related to both the basic and acidic fibroblast growth factors but have different amino acid sequences. (12 Dec 1998) |
| endothelial leukocyte | Old term for a monocyte, a type of leukocyte thought to be derived from reticuloendothelial tissue. (05 Mar 2000) |
| endothelial-leukocyte adhesion molecule | 115,000 Mw molecule on the surface of endothelial cells that is involved in blood leukocyte attachment to vessel walls as well as emigration from the vessels into the tissues. (05 Mar 2000) |
| endothelial myeloma | A malignant primary bone tumour that arises most commonly in the first three decades of life. It is highly malignant (prone to spread) and often requires treatment with some combination of radiation therapy and chemotherapy. (27 Sep 1997) |
| endothelial relaxing factor | A molecule functioning as a neurotransmitter and produced by activated macrophages. It is capable of killing tumour cells, parasites, and intracellular bacteria. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|